Infectious Diseases and Pharmacology for Primary Care

Infectious Diseases and Pharmacology for Primary Care is organized by MCE Conferences, Inc. and will be held from Mar 25 - 27, 2022 at Dreams Jade Resort & Spa, Riviera Maya, Quintana Roo, Mexico.

Target Audience:
All Physicians and other Healthcare Professionals seeking clinical information about issues in Infectious Diseases and Pharmacology.

Overview:
This conference is designed to provide primary care practitioners with up-to-date, evidence-based information on commonly encountered issues in Infectious Diseases and Pharmacology, while suggesting pragmatic approaches to clinical management. The discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Infectious Diseases and Pharmacology, with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.

Topics and Objectives:
Infectious Diseases 
Skin and Soft Tissue Infections
Objective:
• Review terminology, anatomy, pathophysiology, clinical presentation, and management of skin and soft tissue infections, including impetigo, hair follicle-associated infections, erysipelas, cellulitis, and necrotizing fasciitis? 

Primary Care-Associated Infections: Part 1
Objective:
• Review the approach to selected primary care infectious disease topics including urinary tract infections, pharyngitis, and endocarditis prophylaxis in a case-based format? 

Primary Care-Associated Infections: Part 2
Objective:
• Review the approach to primary care infectious diseases including selected viral infections, diarrheal infections and recreational water-associated infections 

Clostridioides?difficile
Objectives:
• Review current epidemiology, clinical presentation and diagnosis of?Clostridioides?difficile?infections
• Provide updated treatment strategies for treatment of?C. difficile?infections

Infectious Diseases 2022: An Update
Objective:
• Identify some of the most significant recent papers and topics that highlight emerging themes in infectious diseases (other than COVID-19) 

Mimics of Infectious Diseases
Objective:
• To review several case-based presentations which MAY or MAY NOT be due to an infectious disease? 

Pharmacology
Alphabet Soup Part 1: Pharmacotherapy Updates in Lipid Management with Focus on the High-Risk Patient
Objectives:
• Summarize recommendations from clinical practice guidelines regarding lipid-lowering therapy 
• Discuss medication optimization for secondary prevention for the patient
• Develop a therapeutic plan for the patient with complex lipid-lowering needs 

Alphabet Soup Part 2: Pharmacotherapy Updates in Lipid Management and the Role of Non-Statin Therapies
Objectives:
• Summarize recommendations from clinical practice guidelines regarding lipid-lowering therapy 
• Discuss clinical evidence and place in therapy for non-statin agents
• Develop a therapeutic plan for the patient with complex lipid-lowering needs 

Alphabet Soup Part 3: Hypertension Medication Management in Primary Care
Objectives:
• Summarize recommendations from clinical practice guidelines regarding hypertension
• Discuss evidence-based optimization for antihypertensives
• Develop a therapeutic plan for the patient with resistant hypertension 

“First Comes Metformin, and Then Comes…?”: Evaluating the Role of Oral Agents for Type 2 Diabetes
Objectives:
• Summarize recommendations from clinical practice guidelines regarding diabetes
• Discuss clinical evidence and place in therapy for newly approved oral diabetes agents
• Develop a therapeutic plan for the patient with diabetes 

Injectable Products for Diabetes – Part 1
Objectives:
• Summarize recommendations from clinical practice guidelines regarding diabetes
• Discuss clinical evidence and place in therapy for GLP-1 agonists
• Develop a therapeutic plan for the patient with diabetes 

Injectable Products for Diabetes – Part 2: The Ins and Outs of Insulin
Objectives:
• Summarize recommendations from clinical practice guidelines regarding diabetes
• Discuss clinical evidence and place in therapy for newly approved insulin products
• Develop a therapeutic plan for the patient with diabetes